Companies / SurGenTec

Medical device company profile

SurGenTec

Privately held manufacturer of spine and orthopedic implants, graft materials and surgical instruments.

Private manufacturerOrthopedics & MusculoskeletalSpineCommercial stage

Headquarters🇺🇸Boca Raton, Florida, United States

Founded2016

Commercial statusCommercially availableCurrent marketed U.S. portfolio; licensed and internally developed products

EmployeesNot confirmed

Estimated revenueNot confirmed

Official websitewww.surgentec.com ↗

Company overview

SurGenTec is a privately held medical device company based in Boca Raton, Florida. Its company history dates its founding by Travis Greenhalgh to 2016. The current portfolio spans facet fixation, sacroiliac joint fusion, synthetic bone grafts, allografts, graft-delivery instruments and surgical access tools. Flagship families include ION, TiLink, OsteoFlo and GraftGun.

The company markets products to spine and orthopedic surgeons and works through distribution relationships. Recent activity includes cervical and lumbar facet fixation clearances and navigation-compatible instruments. In October 2026, it announced an exclusive license for Allevion Medical's Vantage lumbar decompression technology, now listed in SurGenTec's portfolio. That FDA clearance predates the license and remains attributed to Allevion; compatibility with another manufacturer's navigation platform is not itself evidence of a corporate partnership.

Evidence varies across products. Published HydroFiber research includes a rabbit fusion model, while a manufacturer GraftRasp white paper describes three clinical cases and company announcements describe ION-C clinical follow-up. These sources should not be combined into a broad claim of human clinical superiority. FDA-cleared uses remain device-specific. Public revenue, funding-round totals, audited customer counts and confirmed payer coverage were not established in this review.

^{[50][85][86][88][89][90][107][108]}

Leadership

2 people

Travis GreenhalghFounder · Chief Executive Officer ^[85][108]

Matt MartaVice President · Sales ^[88]

Products & regulatory status How does MedTechIndex get this information?

Summary

The reviewed portfolio contains 510(k)-cleared devices and graft products with different regulatory bases. ION facet fixation records include FDA's unclassified device category, which is distinct from a recall hazard class. Allograft catalog listings do not automatically establish clearance, approval or exemption. Exact labeled uses and concurrent-device requirements govern each device. ^{[75][85][89][5][4][103][95][3]}

No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. ^[48][42]

Regulatory snapshot How to read this snapshot

U.S. FDA

32
510(k) clearances: 0
De Novo grants: 0
PMA approvals: 0
Recall events

Latest recorded source review: 2026-10-20.

Commercial portfolio snapshot

Documented commercial product families.

Bone graft delivery system